Nervous System Channel
Topics
Medications
Quicklinks
Related Channels
Orally Disintegrating Selegiline
Orally disintegrating selegiline is a medication approved to treat symptoms associated with Parkinson's disease. This prescription medication can only be used in combination with carbidopa-levodopa medications. Before taking orally disintegrating selegiline, make sure your healthcare provider is aware of all other medical conditions you have and any other medications you are taking (including vitamins and supplements).
Interested in a Discount on Orally Disintegrating Selegiline?
Enter your email address to see if eMedTV's free DiscountRx service has a program that could help you save on your prescription(s).
Thank you!
Thank you for your interest in DiscountRx from eMedTV. An email has been sent to the address you provided. Please follow the link within that email to see what offers may be available.
Orally disintegrating selegiline (Zelapar®) is a prescription medication licensed to treat Parkinson's disease. It is approved for use in combination with carbidopa-levodopa medications (such as Sinemet®, Sinemet CR®, or Parcopa®). Because orally disintegrating selegiline tablets dissolve rapidly on the tongue without any need for water, they are especially useful for people who have difficulty swallowing tablets.
(Click What Is Orally Disintegrating Selegiline Used For? for more information, including possible off-label uses.)
As with any medicine, side effects are possible with orally disintegrating selegiline. Although some side effects may be merely bothersome, some are quite serious or intolerable. Side effects often limit the usefulness of the drug.
Common side effects of orally disintegrating selegiline include but are not limited to:
- Dizziness
- Nausea
- Pain
- Insomnia.
(Click Side Effects of Orally Disintegrating Selegiline to learn more, including potentially serious side effects you should report immediately to your healthcare provider.)
Written by/reviewed by: Kristi Monson, PharmD; Arthur Schoenstadt, MD
Last reviewed by: Kristi Monson, PharmD